Brief Articles
Journal of Medicinal Chemistry, 2006, Vol. 49, No. 18 5629
H-6), 9.16 (NH). MS: calcd for C23H40O7N2S2Si2Na [M + Na]+
599.84, found 599.80. Mp 51-53 °C. Anal. (C23H40O7N2S2Si2) C,
H, N.
Table 1. Mean Cytotoxicities of Leinamycin Antibiotic Analogues
toward Human Cancer Cellsa
cytotoxicity
1-((2′R,4′S,5′S)-4′-(tert-Butyldimethylsilyloxy)-5′-((S)-[5′′-(2′′,5′′-
dioxo-1′′,2′′-dithiolan-3′′-yl)]-tetrahydrofuran-2′-yl]-5-methylpy-
rimidine-2,4(1H,3H)-dione (23b). To a solution of 23a (222 mg,
0.50 mmol) in dry acetone (25 mL) was added a dimethyldioxirane
solution (6.25 mL, C ) 0.080 mol/L, 1.0 equiv), and the mixture
was stirred at room temperature for 2 h. Evaporation gave 23b (216
mg, 94% yield), as a pale yellow solid, TLC: Rf 0.33 (D: 8:2
hexanes-EtOAc). 1H NMR (400 MHz, CDCl3) δ 0.17 (6H, s, Si-
(CH3)2), 0.89 (9H, s, C(CH3)3), 1.89 (3H, s, C(CH3)), 2.32 (2H, m,
H-3′), 3.14 (2H, d, J ) 8 Hz, H-4′′), 3.25 (1H, m, H-3′′), 4.10
(1H, m, H-4′), 4.59 (1H, m, H-5′), 6.13 (1H, dt (restricted rotation),
H-2′), 7.39 (1H, d, J ) 4 Hz, H-6), 8.44 (NH). MS: calcd for
C18H29S2O6N2Si [M + H]+ 461.73, found 461.76. Mp 54-56 °C.
Anal. (C18H28S2O6N2Si) C, H, N.
a
compound
IC50
IC50a (+EtSHb)
CLogP
daunomycin
9
10
13
14
18a
18b
19a
19b
23a
23b
24a
24b
28a
28b
2.96
-
-1.621
3.607
1.875
2.338
0.634
5.397
3.694
-1.449
-3.152
2.766
257.7
68.43
35.93
18.15
10.04
3.68
62.23
50.71
n.d.
43.12
298.8
118.7
123.7
62.88
65.54
24.75
16.87
12.60
7.84
2.67
20.72
7.01
16.69
6.61
54.62
29.69
20.11
8.33
1.063
-0.615
-2.318
2.831
5-(5′-(Tetrahydro-2H-pyran-2′-yloxy)pent-3′-ynyl)-1,2-dithi-
olan-3-one-1-oxide (28b). To a solution of 28a (70 mg, 0.245
mmol) in acetone (5 mL) was added a dimethyldioxirane solution
(3.65 mL, C ) 0.067 mol/L, 1.0 equiv), and the mixture was stirred
at room temperature for 2 h. Following concentration, the product
28b (73 mg, 98% yield) was isolated as a yellow syrup, TLC: Rf
1.009
a Cytoxicity values are micromolar concentrations (µM) corresponding
to 50% growth inhibition. b Ethanethiol.
indicate that in the case of the pair of compounds 23a/24a, 23b/
24b, 18a/19a, and 18b/19b carrying the silyl-protecting group
and the free hydroxyl, respectively, the cytotoxicity of the
lipophilic silyl compounds is higher than that of the respective
pair with a negative CLogP value. Compound 28b, which carries
a triple bond analogue of the molecular fragment of leinamycin
responsible for the DNA cleaving effect, is also a comparatively
active member of the series.
The cytotoxicity of simple leinamycin analogues has not been
extensively investigated. The results presented here demonstrate
that some derivatives of leinamycin with very simplified
structures, such as the dithiolanone-S-oxides, possess compara-
tive efficacy. Therefore further investigations of related com-
pounds may be worthwile. For this purpose, noncomplicated,
convenient synthetic procedures such as that described in this
paper can be extended to additional aldehydes. It is believed
that we have also succeeded in proving the cytotoxicity-
enhancing properties of silyl ethers, first reported by Padron et
al.,22 by using completely different structures, and this encour-
ages further systematic studies on the topic.
1
0.15 (C: 9:1 hexanes-EtOAc). H NMR (400 MHz, CDCl3) δ
1.54-1.75 (6H, m, THP), 2.00-2.12 (2H, m, H-1′), 2.45-2.51
(2H, s, H-2′), 2.68-2.76 and 3.04-3.12 (2H, dd, H-4), 3.51-3.55
(2H, m, THP), 3.70-3.87 (2H, m, H-5′), 4.16-4.33 (1H, q, H-5),
4.74 (1H, t, THP). MS: calcd for C13H18O4S2Na [M + Na]+ 325.04,
found. 325.01. Anal. Calcd for (C13H18O4S2 C) C, H, N.
Acknowledgment. This work was supported by the Hungar-
ian Academy of Sciences and the National Scientific Research
Found Grants No.: OTKA 42512 and RET-06/2004.
Supporting Information Available: Experimental procedures
and characterization data for all compounds. This material is
References
(1) Hara, M.; Takahashi, I.; Yoshida, M.; Asano, K.; Kawamoto, I.;
Morimoto, M.; Nakano, H. DC 107, a Novel Antitumor Antibiotic
Produced by a Streptomyces sp. J. Antibiot. 1989, 42, 333-335.
(2) Hara, M.; Assano, K.; Kawamoto, I.; Takiguchi, T.; Katsumata, S.;
Takahashi, K.-I.; Nakano, H. Leinamycin, a New Antitumor Anti-
biotic from Streptomyces: Producing Organism, Fermentation and
Isolation. J. Antibiot. 1989, 42, 1768-1774.
(3) Hara, M.; Saitoh, Y.; Nakano, H. DNA Strand Scission by the Novel
Antitumor Antibiotic Leinamycin. Biochemistry 1990, 29, 5676-5681.
(4) Hirayama, N.; Matsuzawa, E. Molecular Structure of a Novel
Antitumor Antibiotic Leinamycin. Chem. Lett. 1993, 22, 1957-1958.
(5) Kanda, Y.; Saito, H.; Fukuyama, T. Synthetic Studies on Leinamycin.
A Synthesis of the 1-Oxo-1,2-Dithiolan-3-One Moiety. Tetrahedron
Lett. 1992, 33, 5701-5704.
Experimental Section
1H and 13C NMR spectra were recorded at 400.13 and 100.61
MHz, respectively, with a Bruker WP-400 SY spectrometer, or at
360.13 and 90.55 MHz, respectively, with a Bruker WP-360 SY
spectrometer. Mass spectra were recorded with Bruker Biflex-III
MALDI TOF MS (matrix-assisted laser desorption time-of-flight
mass spectrometry) and Bruker BioTOF II ESI TOF (electrospray
ionization time-of-flight) mass spectrometers. For column chro-
matography, Merck silica gel (Kieselgel 60), 0.063-0.200 mm
(70-230 mesh), was used. Thin-layer chromatography (TLC) was
performed on Kieselgel 60 F254 (Merck). The synthesis of key final
compounds 18b, 23b, and 28b are indicated below. For more
information, see Supporting Information.
1-((2′R,3′R,4′R,5′S)-3′,4′-Bis(tert-butyldimethylsilyloxy)-5′-
((S)-[5′′-(2′′,5′′-dioxo-1′′,2′′-dithiolan-3′′-yl)]-terahydrofuran-2′-
yl)pyrimidin-2,4(1H,3H)-dione (18b). To a pale yellow solution
of 18a (55 mg, 0.099 mmol) in dry acetone (5 mL) was added a
dimethyldioxirane solution (1.60 mL, C ) 0.062 mol/L, 1.0
equivalent), and the mixture was stirred at room temperature for 2
h. Evaporation furnished a colorless solid 18b (54.7 mg, 96% yield).
TLC: Rf 0.33 (F: 7:3 hexane-acetone). 1H NMR (400 MHz,
CDCl3) δ 0.09-0.14 (12H, s, Si(CH3)2), 0.91-0.95 (18H, s,
C(CH3)3), 3.12 (2H, m, H-4′′), 4.11 (1H, t, H-5′), 4.21 (1H, m,
H-3′′), 4.42 (1H, t, H-4′), 4.89 (1H, s, H-3′), 5.59-5.61 (1H, d,
H-2′), 5.70-5.75 (1H, q, H-5), 7.10-7.13 and 7.53-7.56 (1H, dd,
(6) Kanda, Y.; Fukuyama, T. Total Synthesis of (+) Leinamycin. J. Am.
Chem. Soc. 1993, 115, 8451-8452.
(7) Kanda, Y.; Ashizawa, T.; Saitoh, Y.; Saito, H.; Gomi, K.; Okabe,
M. Synthesis and Antitumor Activity of Leinamycin Derivatives:
Modifications of C-8 Hydroxy and C-9 Keto Groups. Bioorg. Med.
Chem. Lett. 1998, 8, 909-912.
(8) Kanda, Y.; Ashizawa, T.; Kakita, S.; Takahashi, Y.; Kono, M.;
Yoshida, M.; Saitoh, Y.; Okabe, M. Synthesis and Antitumor Activity
of Novel Thioester Derivatives of Leinamycin. J. Med. Chem. 1999,
42, 1330-1332.
(9) Gates, K. S. Mechanisms of DNA Damage by Leinamycin. Chem.
Res. Toxicol. 2000, 13, 953-956.
(10) Asai, A.; Hara, M.; Kakita, S.; Kanda, Y.; Yoshida, M.; Saito, H.;
Saitoh, Y. Thiol-Mediated DNA Alkylation by the Novel Antitumor
Antibiotic Leinamycin. J. Am. Chem. Soc. 1996, 118, 6802-6803.
(11) Behroozi, S. J.; Kim, W.; Dannaldson, J.; Gates, K. S. 1,2-Dithiolan-
3-One 1-Oxides: A Class of Thiol-Activated DNA-Cleaving Agents
that are Structurally Related to the Natural Product Leinamycin.
Biochemistry 1996, 35, 1768-1774.
(12) Mitra, K.; Kim, W.; Daniels, J. S.; Gates, K. S. Oxidative DNA
Cleavage by the Antitumor Antibiotic Leinamycin and Simple 1,2-
Dithiolan-3-One 1-Oxides: Evidence for Thiol-Dependent Conver-
sion of Molecular Oxygen to DNA-Cleaving Oxygen Radicals
Mediated by Polysulfides. J. Am. Chem. Soc. 1997, 119, 11691-
11692.